Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nurse video calls may boost oral health in COPD patients

NCT ID NCT07462221

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 20-minute video call with a nurse, who teaches about oral hygiene, can improve mouth health in people with COPD. Researchers will compare oral health scores and quality of life between a group that gets the video call and a group that does not. The trial aims to enroll 80 adults with COPD who are currently in the hospital.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telenursing (oral health education via video call)
What this could lead to
If it works, this could show that remote nursing support helps COPD patients maintain better oral hygiene and quality of life.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The intervention is behavioral, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must have been diagnosed with COPD for at least 6 months, * receive inpatient treatment in internal medicine and surgical clinics, * signed the informed consent form to participate in the study, * have internet access and a mobile device with Android/iOS operating system, * be able to use a phone, * ≥ 40 years old, * have no communication barriers, * mild (Stage 1), moderate (Stage 2), severe (Stage 3), or very severe (Stage 4) stages according to the GOLD (2023) report. Exclusion Criteria: * Those diagnosed with COPD less than 6 months ago, * Those receiving outpatient treatment, * Those hospitalized in the intensive care unit, * Those without internet access and a mobile device with Android/iOS operating system, * Those who do not have the ability to use a phone, * Those under 40 years of age, * Those with communication barriers, * Those who wish to withdraw from the research/withdraw from participation during the research process,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University

    RECRUITING

    Çanakkale, 17100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.